These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 23650473)

  • 1. Review of the treatment of restless legs syndrome: focus on gabapentin enacarbil.
    Burke RA; Faulkner MA
    J Cent Nerv Syst Dis; 2012; 4():147-56. PubMed ID: 23650473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A mixed treatment comparison of gabapentin enacarbil, pramipexole, ropinirole and rotigotine in moderate-to-severe restless legs syndrome.
    Sun Y; van Valkenhoef G; Morel T
    Curr Med Res Opin; 2014 Nov; 30(11):2267-78. PubMed ID: 25050588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gabapentin enacarbil for the treatment of restless legs syndrome (RLS).
    Burke RA; Faulkner MA
    Expert Opin Pharmacother; 2011 Dec; 12(18):2905-14. PubMed ID: 22077768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of gabapentin enacarbil in the treatment of restless legs syndrome.
    Yaltho TC; Ondo WG
    Ther Adv Neurol Disord; 2010 Sep; 3(5):269-75. PubMed ID: 21179617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gabapentin enacarbil for treatment of restless legs syndrome in adults.
    Hayes WJ; Lemon MD; Farver DK
    Ann Pharmacother; 2012 Feb; 46(2):229-39. PubMed ID: 22298601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gabapentin enacarbil - clinical efficacy in restless legs syndrome.
    Agarwal P; Griffith A; Costantino HR; Vaish N
    Neuropsychiatr Dis Treat; 2010 May; 6():151-8. PubMed ID: 20505847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gabapentin Enacarbil: A Review in Restless Legs Syndrome.
    Kim ES; Deeks ED
    Drugs; 2016 May; 76(8):879-87. PubMed ID: 27146056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gabapentin enacarbil: in patients with restless legs syndrome.
    Scott LJ
    CNS Drugs; 2012 Dec; 26(12):1073-83. PubMed ID: 23179641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dose response of Gabapentin Enacarbil versus placebo in subjects with moderate-to-severe primary restless legs syndrome: an integrated analysis of three 12-week studies.
    VanMeter SA; Kavanagh ST; Warren S; Barrett RW
    CNS Drugs; 2012 Sep; 26(9):773-80. PubMed ID: 22849331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gabapentin enacarbil, a gabapentin prodrug for the treatment of the neurological symptoms associated with disorders such as restless legs syndrome.
    Merlino G; Serafini A; Young JJ; Robiony F; Gigli GL; Valente M
    Curr Opin Investig Drugs; 2009 Jan; 10(1):91-102. PubMed ID: 19127491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Restless legs syndrome: pathophysiology and modern management.
    Nagandla K; De S
    Postgrad Med J; 2013 Jul; 89(1053):402-10. PubMed ID: 23524988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gabapentin enacarbil, pregabalin and rotigotine are equally effective in restless legs syndrome: a comparative meta-analysis.
    Iftikhar IH; Alghothani L; Trotti LM
    Eur J Neurol; 2017 Dec; 24(12):1446-1456. PubMed ID: 28888061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of gabapentin enacarbil on restless legs syndrome and leg pain in dementia with Lewy bodies.
    Fujishiro H
    Psychogeriatrics; 2014 Jun; 14(2):132-4. PubMed ID: 24528871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gabapentin enacarbil for the treatment of moderate to severe primary restless legs syndrome (Willis-Ekbom disease): 600 or 1,200 mg dose?
    Kume A
    Neuropsychiatr Dis Treat; 2014; 10():249-62. PubMed ID: 24523590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. What treatment works best for restless legs syndrome? Meta-analyses of dopaminergic and non-dopaminergic medications.
    Hornyak M; Scholz H; Kohnen R; Bengel J; Kassubek J; Trenkwalder C
    Sleep Med Rev; 2014 Apr; 18(2):153-64. PubMed ID: 23746768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New treatment options for the management of restless leg syndrome.
    Toro BE
    J Neurosci Nurs; 2014 Aug; 46(4):227-32. PubMed ID: 24992148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gabapentin enacarbil in restless legs syndrome.
    Merlino G; Serafini A; Lorenzut S; Sommaro M; Gigli GL; Valente M
    Drugs Today (Barc); 2010 Jan; 46(1):3-11. PubMed ID: 20200691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of gabapentin enacarbil XR in restless legs syndrome.
    Sivam S; Yee BJ
    Ther Clin Risk Manag; 2012; 8():201-8. PubMed ID: 22570552
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment initiation and utilization patterns of pharmacotherapies for early-onset idiopathic restless legs syndrome.
    Costales B; Vouri SM; Brown JD; Setlow B; Goodin AJ
    Sleep Med; 2022 Aug; 96():70-78. PubMed ID: 35605349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gabapentin enacarbil: pharmacotherapy of restless legs syndrome.
    Jones R; Rickards H; Cavanna AE
    J Cent Nerv Syst Dis; 2010; 2():45-55. PubMed ID: 23861631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.